This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Acquisition Remove Develop Remove Long Beach Remove Pricing
article thumbnail

Obagi, Valeant Raise Price As Bidding War Breaks Out

socalTECH

APRIL 3, 2013

Long Beach-based aesthetic medicine developer Obagi Medical Products , and would-be acquirer Valeant Pharmaceuticals , which is based in Aliso Viejo, said this morning that Valeant has raised its offer to acquire Obagi to $24.00 per share in cash. The move comes a day after Obagi said it received an unsolicited bid of $22.00

Long Beach 157
Long Beach Pricing Product Develop 157
article thumbnail

Valeant Pharmaceuticals Buys Obagi Medical For $360M

socalTECH

MARCH 20, 2013

Long Beach-based Obagi Medical Products , the developer of aesthetic medicine products, is being acquired by Valeant Pharmaceuticals , in a deal worth approximately $360M, Obagi said this morning. per share in cash, a 42 percent premium to Obagi's closing share price on Thursday, March 14th. READ MORE>>.

Long Beach 157
Long Beach Pricing Product Develop 157
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 5,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024